Draft:Yunlong Cao

  • Comment: The sources given are primary sources (works made by the subject), and don't establish notability on Wikipedia. If you are connected to the subject, please thoroughly read WP:COI. LR.127 (talk) 22:52, 12 August 2024 (UTC)


Yunlong Richard Cao
曹云龙
Alma materHarvard University
Known forSARS-CoV-2 evolution
AwardsNature's 10 (2022)
Scientific career
FieldsImmunology
InstitutionsBiomedical Pioneering Innovation Center, Peking University

Yunlong Richard Cao Chinese:曹云龙; pinyin: Cáo Yúnlóng) is a Chinese immunologist and assistant professor at Peking University's Biomedical Pioneering Innovation Center (BIOPIC).[1][2] Known for his work on SARS-CoV-2 evolution and antibody responses, Cao has made significant contributions to understanding humoral immunity and developing antibody therapeutics.[3][4]His research focuses on B-cell mediated adaptive immune response, antibody drugs, and vaccine design.[5] Cao gained international recognition for his ability to predict SARS-CoV-2 mutations and was named one of Nature's "Ten People Who Mattered" in 2022 for his role in tracking the evolution of the virus.[6] He was also listed as one of the "Innovators under 35" by the MIT Technology Review in 2021.[7]

  1. ^ "Yunlong Cao, PhD". BIOPIC, PKU. Retrieved 10 August 2024.
  2. ^ "Yunlong Cao, PhD". Peking-Tsinghua Center for Life Sciences. Retrieved 10 August 2024.
  3. ^ "Cao Lab". Biomedical Pioneering Innovation Center (BIOPIC). Beijing, China: Peking University.
  4. ^ "Yunlong Cao_Nature's 10". Pandaily. Retrieved 29 October 2024.
  5. ^ Liu C. Wellington D (ed.). "Assistant Professor Yunlong Cao visits CAMS Oxford Institute". CAMS Oxford Institute, Nuffield Department of Medicine. University of Oxford.
  6. ^ "2022 Nature's 10". Nature. Springer Nature Limited. Retrieved 10 August 2024.
  7. ^ Cite error: The named reference MIT_2021 was invoked but never defined (see the help page).